CRST programs progress through different stages of maturity. Access may include early participation, waiting lists, pilot deployments, collaboration, licensing, public release, or support pathways depending on the program.
For mature public-facing systems where controlled use can improve the work and serve qualified users. MPA is the likely first candidate for this pathway.
Early access should be treated as participation in a controlled release, not as a discount label.
Research, licensing, manufacturing, publication, development, or technical partnership conversations may be appropriate when aligned with a CRST domain or program.
Collaboration is most useful when it strengthens the work rather than redirecting it.
Grants, donations, sponsorship, investment conversations, equipment support, or material resources may be accepted when they strengthen CRST’s research-first posture.
Support routes should serve capability, not replace commercial discipline.
Access to CRST products and services depends on program stage. A public program may support a waiting list, Early Access, beta participation, pilot deployment, full public production, licensing, or private correspondence. Deferred and internal programs may have no access route until the work matures.
Visitors seeking a specific system should begin with the relevant program or highlight. General access routes may be used for collaboration, support, licensing, or participation inquiries where no dedicated product page exists.
As MPA approaches release, this page will likely become more operational. Until then, it should establish the major pathways without implying that every pathway is active at the same time.